Works matching IS 03682811 AND DT 2019 AND VI 49 AND IP 2


Results: 15
    1
    2
    3

    Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 190, doi. 10.1093/jjco/hyy190
    By:
    • Motoi, Fuyuhiko;
    • Kosuge, Tomoo;
    • Ueno, Hideki;
    • Yamaue, Hiroki;
    • Satoi, Sohei;
    • Sho, Masayuki;
    • Honda, Goro;
    • Matsumoto, Ippei;
    • Wada, Keita;
    • Furuse, Junji;
    • Matsuyama, Yutaka;
    • Unno, Michiaki;
    • (JSAP), Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    IN THIS ISSUE.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 1, doi. 10.1093/jjco/hyz014
    Publication type:
    Article
    15

    dose-finding randomized Phase II study of oral netupitant in combination with palonosetron.75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 121, doi. 10.1093/jjco/hyy161
    By:
    • Osaki, Akihiko;
    • Inoue, Kenichi;
    • Sakai, Hiroshi;
    • Yamada, Kazuhiko;
    • Minato, Koichi;
    • Ohyanagi, Fumiyoshi;
    • Tokuda, Yutaka;
    • Ikeda, Norihiko;
    • Kagamu, Hiroshi;
    • Kubota, Kaoru;
    • Tamura, Tomohide;
    • Saeki, Toshiaki
    Publication type:
    Article